Aims

The overall aim of the SMILe project is the development, implementation, testing and evaluation of an Integrated Care Model for SteM cell transplantatIon faciLitated by eHealth (SMILe-ICM).

To reach the overall aim, we followed the two phases of Development and Implementation (Phase A) as well as the Testing and Evaluation (Phase B) by completing the following sub-aims:

Phase A:

1) To identify the target organizations’ structural characteristics and practice patterns in view of chronic illness management; to assess how self-management and behavioral support is currently being supported; and to assess the technology openness of clinicians and alloSCT patients regarding eHealth use along the eCCM dimensions by performing a contextual analysis.  (See publication)

2) To develop/adapt the SMILe-Integrated Care Model (SMILe-ICM)  by combining implementation , behavioral  and computer science methods and to choose adequate implementation strategies per target setting. (See publication)

Phase B:

To test the SMILe-ICM and to evaluate the implementation of the SMILe-ICM regarding feasibility, acceptability, appropriateness and fidelity and the implementation pathway in the first year post-alloSCT.